We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
9301
PUT
Cytokinetics
CYTK
$10.5B
$643K ﹤0.01%
32,500
+6,000
+23% +$141K
DRIP icon
9302
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$100M
$643K ﹤0.01%
906
-2,303
-72% -$2.21M
LOV
9303
DELISTED
Spark Networks SE American Depositary Shares
LOV
$643K ﹤0.01%
124,182
+86,239
+227% +$540K
ADAP
9304
DELISTED
Adaptimmune Therapeutics
ADAP
$642K ﹤0.01%
150,602
-2,324,950
-94% -$11.3M
EBC icon
9305
PUT
Eastern Bankshares
EBC
$5.4B
$642K ﹤0.01%
31,200
+9,800
+46% +$208K
SPAK
9306
CALL
DELISTED
Defiance Next Gen SPAC Derived ETF
SPAK
$642K ﹤0.01%
24,300
-4,100
-14% -$104K
SLY
9307
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$642K ﹤0.01%
+6,573
New +$635K
IXC icon
9308
CALL
iShares Global Energy ETF
IXC
$2.8B
$641K ﹤0.01%
24,100
+2,300
+11% +$59.7K
NGL icon
9309
PUT
NGL Energy Partners
NGL
$2.29B
$640K ﹤0.01%
268,900
-21,500
-7% -$48.2K
PNR icon
9310
Pentair
PNR
$10.6B
$640K ﹤0.01%
9,480
-78,093
-89% -$5.17M
UPGD icon
9311
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$120M
$640K ﹤0.01%
10,399
+3,142
+43% +$190K
XPOA.WS
9312
DELISTED
DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at
XPOA.WS
$640K ﹤0.01%
+496,213
New +$609K
BLKB icon
9313
Blackbaud
BLKB
$2.05B
$639K ﹤0.01%
8,349
-111,764
-93% -$8.06M
CLB icon
9314
PUT
Core Laboratories
CLB
$571M
$639K ﹤0.01%
16,400
+8,200
+100% +$294K
DNB
9315
PUT
DELISTED
Dun & Bradstreet
DNB
$639K ﹤0.01%
29,900
-382,000
-93% -$8.55M
SNCR
9316
PUT
DELISTED
Synchronoss Technologies
SNCR
$639K ﹤0.01%
19,778
+17,056
+627% +$480K
SPHD icon
9317
PUT
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.42B
$639K ﹤0.01%
14,500
+500
+4% +$22.3K
RTL
9318
PUT
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$639K ﹤0.01%
+75,300
New +$703K
EQOS
9319
CALL
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$639K ﹤0.01%
97,600
+37,700
+63% +$262K
KNL
9320
CALL
DELISTED
Knoll, Inc.
KNL
$639K ﹤0.01%
+24,600
New +$587K
CPRX
9321
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$638K ﹤0.01%
110,900
+80,800
+268% +$417K
ICU icon
9322
SeaStar Medical
ICU
$12.7M
$638K ﹤0.01%
258
+44
+21% +$109K
LNTH icon
9323
PUT
Lantheus
LNTH
$6.59B
$638K ﹤0.01%
+23,100
New +$530K
OCFT
9324
PUT
DELISTED
OneConnect Financial Technology
OCFT
$638K ﹤0.01%
+5,310
New +$761K
RYTM icon
9325
Rhythm Pharmaceuticals
RYTM
$7.95B
$638K ﹤0.01%
32,574
-86,134
-73% -$1.79M

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.